Koyfin Home > Directory > Health Care > Arcus Biosciences Inc > Cash and Short-Term Investments

Arcus Biosciences Inc Cash and Short-Term Investments Chart (RCUS)

Arcus Biosciences Inc annual/quarterly Cash and Short-Term Investments from 2017 to 2018.
  • Arcus Biosciences Inc Cash and Short-Term Investments for the quarter ending December 12, 2018 was $257m a -9.21% decrease of -24m year over year
  • Arcus Biosciences Inc Cash and Short-Term Investments for the last 12 months ending December 12, 2018 was $257m a -9.21% decrease of -24m year over year
  • Arcus Biosciences Inc Annual Cash and Short-Term Investments for 2018 was $257m a 31.51% increase of 81m from 2017
  • Arcus Biosciences Inc Annual Cash and Short-Term Investments for 2017 was $176m a 43.71% increase of 77m from 2016
  • Arcus Biosciences Inc Annual Cash and Short-Term Investments for 2016 was $99m
Other Balance Sheet Metrics:
  • Arcus Biosciences Inc Total Assets for the quarter ending December 12, 2018 was $275m a -11.08% decrease of -30m year over year
  • Arcus Biosciences Inc Other Liabilities for the quarter ending December 12, 2018 was $23m a -6.50% decrease of -1m year over year
  • Arcus Biosciences Inc Total Equity for the quarter ending December 12, 2018 was $235m a -13.47% decrease of -32m year over year
View Chart On Koyfin

Quarterly RCUS Cash and Short-Term Investments Data

12/2018$257m
09/2018$258m
06/2018$266m
03/2018$280m
12/2017$176m
03/2017$99m

Annual RCUS Cash and Short-Term Investments Data

2018$257m
2017$176m
2016$99m